As for ACE2 protein expression, we treated five types of ADs as exposures and peripheral blood ACE2 protein expression level from two GWAS datasets as outcomes to investigate if causal effects of ADs on COVID-19 phenotypes were mediated by the ACE2 expression level. The gene discussed is ACE2; the disease is COVID-19.